New approaches in cancer pharmacology: drug design and development. Report of a European School of Oncology Task Force.
D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D004247:DNA / Q000187:drug effects; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D016376:Oligonucleotides, Antisense; D009857:Oncogenes; D010742:Phospholipid Ethers / Q000627:therapeutic use; D011355:Prodrugs; D015398:Signal Transduction
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D010742:Phospholipid Ethers; D011355:Prodrugs; D004247:DNA